TL;DR: The pharmacokinetic parameters were highly variable among this group of dogs with MMVD, and the variability was not associated with the dog's age, body weight or condition score, stage of heart disease, dose, serum creatinine, or alkaline phosphatase. (via Semantic Scholar)